CCVS: Cardiac Complication After Vascular Surgery

Sponsor
Pomeranian Medical University Szczecin (Other)
Overall Status
Completed
CT.gov ID
NCT03188341
Collaborator
(none)
100
78

Study Details

Study Description

Brief Summary

The vascular surgery is a highest risk procedure when considering postoperative complications associated with the cardiovascular system. The leading clinical presentation is acute hemodynamic decompensation. However, one of the possible pathomechanisms might be repolarization disturbances. Many of perioperative risk factors of cardiac complications are modifiable. The identification may help in the global perioperative risk reduction.

Aim: The aim of the study was an identification of the factors which may release clinically overt repolarization disturbances.

Methods: The study group consisted of 100 patients, diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure. The authors investigated whether age, gender, comorbidities or some perioperative factors (including hemodynamic, metabolic or genetic) were related to the occurrence of clinically concealed repolarization disturbances or clinically disclosed cardiac complications in postoperative time up to 30 day and one year after vascular surgery procedure.

Condition or Disease Intervention/Treatment Phase
  • Other: vascular surgery procedure

Detailed Description

Vascular surgery is thought as the highest risk procedure in the context of cardiac complications. The range may include acute coronary syndrome, acute circulatory failure, severe arrhythmias, syncope and sudden cardiac death. The patient population is considered as a high risk, too. Popular calculators used for risk stratifications are based on preoperative patient's history and some general laboratory results. However, general status of the patient changes dynamically during vascular procedures leading to acquired increased risk. For this reason, sole preoperative risk prediction based on standard calculators is unsuitable and suboptimal. Advanced monitoring systems may record some temporary disturbances (e.g. ventricular repolarization disturbances), which may be asymptomatic. The clinical significance in postoperative risk prediction of such observations remains undefined. On the other hand, many of perioperative cardiac complications are caused by modifiable factors. The identification may help in the global perioperative risk reduction.

Study Design

Study Type:
Observational
Actual Enrollment :
100 participants
Observational Model:
Cohort
Time Perspective:
Prospective
Official Title:
The Reasons of Repolarization Disturbances Disclosure in Vascular Surgery
Actual Study Start Date :
Dec 1, 2010
Actual Primary Completion Date :
Dec 1, 2016
Actual Study Completion Date :
Jun 1, 2017

Arms and Interventions

Arm Intervention/Treatment
vascular surgery patients

clinically concealed repolarization disturbances during vascular surgery procedure clinically disclosed cardiac complications during and after vascular surgery procedure

Other: vascular surgery procedure
an elective "open" vascular surgery procedure ECG Holter recording during the procedure and 24 hours after operation (continuous electrocardiographic tracing (digital Holter ECG monitor)

Outcome Measures

Primary Outcome Measures

  1. cardiac complications [up to 30 days after vascular procedure]

    cardiac complications according to European Society of Cardiology

Secondary Outcome Measures

  1. cardiac complications [during surgical procedure]

    cardiac complications according to European Society of Cardiology

  2. cardiac complications [one year]

    cardiac complications according to European Society of Cardiology

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • adult patients diagnosed with abdominal subrenal aortic aneurysms or peripheral arterial disease scheduled for an elective "open" vascular surgery procedure
Exclusion Criteria:
  • heart stimulation,

  • atrioventricular and intraventricular conduction defects,

  • atrial fibrillation recorded before of the study,

  • antiarrhythmic drug treatment (except beta-blockers),

  • unoptimal patient general status (uncontrolled diabetes, active infection)

  • reoperation

  • emergency operations

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Pomeranian Medical University Szczecin

Investigators

  • Principal Investigator: Jowita Biernawska, MD, PhD, Department of Anaesthesiology and Intensive Care of the Pomeranian Medical University in Szczecin, Poland.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Jowita Biernawska, MD PhD, Pomeranian Medical University Szczecin
ClinicalTrials.gov Identifier:
NCT03188341
Other Study ID Numbers:
  • PomeranianMU
First Posted:
Jun 15, 2017
Last Update Posted:
Jun 15, 2017
Last Verified:
Jun 1, 2017
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Jowita Biernawska, MD PhD, Pomeranian Medical University Szczecin
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 15, 2017